Researchers use 3D printing to develop personalized artificial organs

Researchers from the University of Minnesota used 3D printing to build lifelike artificial organ models that mimic the look, structure, mechanical properties and feel of human organs. Findings were published in Advanced Materials Technologies.

Current organ models use plastic to construct each model, which hampers accuracy in predicting what an actual organ would do during surgery. In response, researchers developed a 3D-printing technique capable of producing patient-specific organ models for surgical practice to improve surgical outcomes.

"We are developing next-generation organ models for pre-operative practice. The organ models we are 3D printing are almost a perfect replica in terms of the look and feel of an individual's organ, using our custom-built 3D printers," said lead researcher Michael McAlpine, an associate professor of mechanical engineering in the University of Minnesota's College of Science and Engineering. "We think these organ models could be 'game-changers' for helping surgeons better plan and practice for surgery. We hope this will save lives by reducing medical errors during surgery.”

Researchers began by colleting MRI scans and prostate tissue samples from patients to develop customized silicon-based inks that can be customized to match the properties of each patient's prostate tissue. Researchers then used the ink with a 3D printer to build the organ and attached sensors, so surgeons can observe the organ during compression tests.

"If we could replicate the function of these tissues and organs, we might someday even be able to create 'bionic organs' for transplants," McAlpine said. "I call this the 'Human X' project. It sounds a bit like science fiction, but if these synthetic organs look, feel, and act like real tissue or organs, we don't see why we couldn't 3D print them on demand to replace real organs."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.